| dc.creator | Faircloth, Glynn | |
| dc.creator | Avilés Marín, Pablo | |
| dc.creator | Lepage, Doreen | |
| dc.creator | San Miguel, Jesús F. | |
| dc.creator | Pandiella, Atanasio | |
| dc.date | 2008-03-18T16:38:49Z | |
| dc.date | 2008-03-18T16:38:49Z | |
| dc.date | 2007-09-07 | |
| dc.date.accessioned | 2017-01-31T01:00:48Z | |
| dc.date.available | 2017-01-31T01:00:48Z | |
| dc.identifier | International Publication Number: WO 2007/101235 A2 | |
| dc.identifier | http://hdl.handle.net/10261/3251 | |
| dc.identifier.uri | http://dspace.mediu.edu.my:8181/xmlui/handle/10261/3251 | |
| dc.description | Filing Date: 2007-02-28.- Priority Data: US 60/813,606 (2006-02-28). | |
| dc.description | The present invention relates to combinations of aplidine or aplidine analogues with other antitumoral agents, and the use of these combinations in the treatment of cancer, in particular in the treatment of lung cancer, breast cancer, colon cancer, prostate cancer, renal cancer, melanoma, multiple myeloma, leukemia and lymphoma. | |
| dc.description | Pharma Mar, S.A.U. | |
| dc.description | Peer reviewed | |
| dc.format | 4545663 bytes | |
| dc.format | application/pdf | |
| dc.language | eng | |
| dc.rights | openAccess | |
| dc.subject | Cancer treatment | |
| dc.subject | Antitumoral agents | |
| dc.subject | Aplidine | |
| dc.title | Improved antitumoral treatments | |
| dc.type | Patente |
| Files | Size | Format | View |
|---|---|---|---|
|
There are no files associated with this item. |
|||